Will these 4 new drugs re-shape the market?

Get the latest in this quarter’s Drug Pipeline Insights Report.

By Sumit Dutta, MD, Chief Medical Officer at Optum Rx­ | Published: March 2022


In this latest Drug Pipeline Insights Report, Optum Rx highlights the four medications expected by the end of the second quarter of 2022. While these new drugs might be safer and more effective, they come at a cost.

The drugs in this report include treatments for:

  • A rare heart condition
  • Plaque psoriasis
  • Type 2 diabetes
  • A cardiovascular disease characterized by an abnormally thick heart muscle

Don't want to read the full report? Download the brief summary.

Download Summary

Icon Picker V2